Prevention of peritonitis.
Piraino
B
B
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002408:Catheters, Indwelling / Q000009:adverse effects*; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D006801:Humans; D016712:Mupirocin / Q000627:therapeutic use; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control*; D012293:Rifampin / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000209:etiology / Q000517:prevention & control*
D000900:Anti-Bacterial Agents; D016712:Mupirocin; D012293:Rifampin